Status: current, Defined. Date: 30-Apr 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2980361000168116 | Provive MCT-LCT 1% (propofol 200 mg / 20 mL) injection, 5 x 20 mL vials (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2980821000168119 | Provive MCT-LCT 1% 200 mg/20 mL injection, 5 x 20 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Provive MCT-LCT 1% 200 mg/20 mL injection, 5 x 20 mL vials | has TP | Provive MCT-LCT 1% | true | Inferred relationship | Some | ||
| Provive MCT-LCT 1% 200 mg/20 mL injection, 5 x 20 mL vials | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Provive MCT-LCT 1% 200 mg/20 mL injection, 5 x 20 mL vials | Is a | Provive MCT-LCT 1% 200 mg/20 mL injection, 5 x 20 mL vials | true | Inferred relationship | Some | ||
| Provive MCT-LCT 1% 200 mg/20 mL injection, 5 x 20 mL vials | has container type | vial | true | Inferred relationship | Some | ||
| Provive MCT-LCT 1% 200 mg/20 mL injection, 5 x 20 mL vials | has TPUU | Provive MCT-LCT 1% (propofol 200 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Western Australia Health Schedule 4 restricted medicines for public hospitals reference set
Containered trade product pack reference set
FHIR